Forbes

Medicare patients are getting access to GLP-1s for obesity through the Bridge program. But questions linger regarding eligibility criteria, prior authorization and costs.

A doctor explains a new study on ultra-processed foods and provides practical advice for parents on how toddlers can eat healthier.

By ending subsidies to standalone prescription drug plans, it’s expected they will have to raise premiums for at least 11 million Medicare beneficiaries.

We have the data. Now how can we inflluence decisions? Wearables can impact our health- but doctors need to be on board.

Healthcare needs more leaders willing to call their babies ugly. This kind of self-indictment will be necessary for the industry to finally begin to make real progress.

Certificate of Need laws block competition and limit patient access by forcing new surgery centers to seek approval from existing providers. Here’s why that matters.

Researchers using medical AI have discovered a hitherto unknown pattern in the humble EKG that indicates an elevated risk for cardiac death.

For profit entities have found ways to bankrupt hospitals they own while making money off their failure.

How six Americans picked retirement spots ranging from Mauritius to France. Start your own search with Forbes’ list of The Best Places To Retire Abroad in 2026.

A physician explains why Medicare Part D premiums may rise in 2027 as CMS ends a drug subsidy — and what patients should do before open enrollment closes Dec. 7.

AI systems have to be pressure-tested in real-world clinical settings to ensure correct reasoning, accuracy and reliability.

Apnimed got a new CEO in anticipation of its public offering. Its pill for sleep apnea could receive approval early next year.

Alignment Healthcare’s second quarter net income more than doubled to $36.6 million compared to the year ago period as costs in its Medicare Advantage plans eased.

Physician shortages are turning speed into healthcare's scarcest resource — and the real investment opportunity is infrastructure, not favors that jump the line.